Adenoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA withdrawal · 2012-06-14
EMA Withdrawn: Docefrez (docetaxel) — Sun Pharmaceutical Industries Europe B.V.
Withdrawn EMA entry for Docefrez (docetaxel) by Sun Pharmaceutical Industries Europe B.V.; listed indications include stomach neoplasms, ade…